Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

The gene URB is more active in human hair growth cells and responds to a hair-related hormone.

In the Jazan region of Saudi Arabia, hair loss is common, especially among women, older people, and those with higher education and BMI. Stress, poor nutrition, and hormonal changes are key causes, but many don't seek medical help.

Amla fruit syrup improved hair growth and satisfaction in women with hair loss without significant side effects.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

The document concludes that understanding hair's chemical makeup is key to creating effective hair growth products that also improve social confidence.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hormone treatment caused hair loss, finasteride helped regrowth.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Red ginseng oil is believed to have various health benefits and is safe, but more research is needed to fully understand how it works.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.